Ocugen price target raised to $8 from $7 at H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth raised the firm’s price target on Ocugen (OCGN) to $8 from $7 and keeps a Buy rating on the shares. The firm says OCU410 continues to show efficacy in geographic atrophy.